miR-486 attenuates cardiac ischemia/reperfusion injury and mediates the beneficial effect of exercise for myocardial protection
Yihua Bei(Shanghai University), Junjie Xiao(Shanghai University), Sunyi Liu(Tongji University), Alessia Costa(Medizinische Hochschule Hannover), Thomas Thum(Medizinische Hochschule Hannover), Shambhabi Chatterjee(Medizinische Hochschule Hannover), Kun Wang(Xuzhou Medical College), Dongchao Lu(Medizinische Hochschule Hannover), Isabelle Riedel(Medizinische Hochschule Hannover), Meiyu Hu(Nantong University), Christian Bär(Medizinische Hochschule Hannover), Zhenzhen Huang(Nantong University), Yujiao Zhu(Shanghai University), Frank C. Mooren(Witten/Herdecke University), Wei Meng(Nantong University), Pujiao Yu(Tongji University)
Cited by 107
Related Papers
Circular RNAs: Promising Biomarkers for Human Diseases
|EBioMedicine|2018|823
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)
|European Journal of Heart Failure|2020|364
miR-29b contributes to multiple types of muscle atrophy
|Nature Communications|2017|245